Bioscience

Celldex Therapeutics has been a tenant at 300 George Street for some 10 years, but the space is now needed by landlord Yale.

Arvinas Inc., a New Haven-based biotechnology company, said Wednesday that its CEO and president plans to retire once a successor is found.

Quantum-Si Inc., a Branford-based biotech company, has announced a $50 million registered direct offering of common stock.

Rallybio Corp., a New Haven-based biotechnology company developing therapies for rare diseases, said Tuesday it has agreed to sell one of those therapies to Utah-based Recursion Pharmaceuticals for up to $25 million.

A New Haven-based biotech company has developed advanced technology that uses gene-editing to improve the quality of lettuce.

A little over two months after it was announced, Germany-based life sciences firm Merck KGaA said Tuesday that it has completed its $3.9 billion acquisition of Stamford-based SpringWorks Therapeutics Inc.

Just six weeks after raising $2.35 million in a public offering, a Shelton-based biotechnology company faces delisting...

As the CEO of BioCT, I have the privilege every day of advancing and promoting Connecticut’s vibrant...

Bactana Corp., a biotech startup headquartered at UConn’s Technology Incubation Program in Farmington, announced Tuesday it has...

New Haven-based biotech company Arvinas Inc. announced Thursday that it’s cutting 131 employees, or about a third...